SEC Form 4 · accession 0001615774-17-003722
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Pappajohn
Director · 10% Owner
Period of report
Jul 17, 2017
Accepted (ET)
Jul 19, 2017 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 17, 2017 | P | 5,000 | $4.40 | A | 511,290 | D | |
| Common Stock | Jul 18, 2017 | P | 5,000 | $4.5389 | A | 516,290 | D |
Table II — derivative securities
No Table II lines on this filing.